These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 33069128)
1. A brief overview on recent advances in spiro[chromane-2,4'-piperidine]-4(3H)-one-functionalized compounds in medicinal chemistry research. Ghatpande NG; Jadhav JS; Kaproormath RV; Soliman ME; Shaikh MM Bioorg Med Chem; 2020 Dec; 28(23):115813. PubMed ID: 33069128 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of spiro[chroman-2,4'-piperidin]-4-one derivatives as acetyl-CoA carboxylase inhibitors. Shinde P; Srivastava SK; Odedara R; Tuli D; Munshi S; Patel J; Zambad SP; Sonawane R; Gupta RC; Chauthaiwale V; Dutt C Bioorg Med Chem Lett; 2009 Feb; 19(3):949-53. PubMed ID: 19097787 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and structure-activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors. Kamata M; Yamashita T; Kina A; Funata M; Mizukami A; Sasaki M; Tani A; Funami M; Amano N; Fukatsu K Bioorg Med Chem Lett; 2012 Jun; 22(11):3643-7. PubMed ID: 22560583 [TBL] [Abstract][Full Text] [Related]
4. Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists. Guo L; Ye Z; Liu J; He S; Bakshi RK; Sebhat IK; Dobbelaar PH; Hong Q; Jian T; Dellureficio JP; Tsou NN; Ball RG; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Chen HY; Chen AS; Martin WJ; MacIntyre DE; Strack AM; Fong TM; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2010 Aug; 20(16):4895-900. PubMed ID: 20621473 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel spiro[chromane-2,4'-piperidine] derivatives as potent and orally bioavailable G-protein-coupled receptor 119 agonists. Koshizawa T; Morimoto T; Watanabe G; Fukuda T; Yamasaki N; Hagita S; Sawada Y; Okuda A; Shibuya K; Ohgiya T Bioorg Med Chem Lett; 2018 Oct; 28(19):3236-3241. PubMed ID: 30145005 [TBL] [Abstract][Full Text] [Related]
6. Potent 3-spiropiperidine growth hormone secretagogues. Yang L; Morriello G; Prendergast K; Cheng K; Jacks T; Chan WW; Schleim KD; Smith RG; Patchett AA Bioorg Med Chem Lett; 1998 Jan; 8(1):107-12. PubMed ID: 9925440 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and structure-activity relationship study of a novel class of ORL1 receptor antagonists based on N-biarylmethyl spiropiperidine. Yoshizumi T; Miyazoe H; Ito H; Tsujita T; Takahashi H; Asai M; Ozaki S; Ohta H; Okamoto O Bioorg Med Chem Lett; 2008 Jul; 18(13):3778-82. PubMed ID: 18515099 [TBL] [Abstract][Full Text] [Related]
8. Novel sigma receptor ligands. Part 2. SAR of spiro[[2]benzopyran-1,4'-piperidines] and spiro[[2]benzofuran-1,4'-piperidines] with carbon substituents in position 3. Maier CA; Wünsch B J Med Chem; 2002 Oct; 45(22):4923-30. PubMed ID: 12383018 [TBL] [Abstract][Full Text] [Related]
10. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists. Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308 [TBL] [Abstract][Full Text] [Related]
11. Spiro-substituted piperidines as neurokinin receptor antagonists. I. Design and synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro [isobenzofuran-1(3H),4'piperidin]-1'-yl)butyl]-N-methylbenzamide, YM-35375, as a new lead compound for novel neurokinin receptor antagonists. Kubota H; Fujii M; Ikeda K; Takeuchi M; Shibanuma T; Isomura Y Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):351-4. PubMed ID: 9501470 [TBL] [Abstract][Full Text] [Related]
12. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis. Smith EM; Sorota S; Kim HM; McKittrick BA; Nechuta TL; Bennett C; Knutson C; Burnett DA; Kieselgof J; Tan Z; Rindgen D; Bridal T; Zhou X; Jia YP; Dong Z; Mullins D; Zhang X; Priestley T; Correll CC; Tulshian D; Czarniecki M; Greenlee WJ Bioorg Med Chem Lett; 2010 Aug; 20(15):4602-6. PubMed ID: 20580233 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors. Wei Q; Mei L; Yang Y; Ma H; Chen H; Zhang H; Zhou J Bioorg Med Chem; 2018 Aug; 26(14):3866-3874. PubMed ID: 30049586 [TBL] [Abstract][Full Text] [Related]
14. Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors. Kamata M; Yamashita T; Kina A; Tawada M; Endo S; Mizukami A; Sasaki M; Tani A; Nakano Y; Watanabe Y; Furuyama N; Funami M; Amano N; Fukatsu K Bioorg Med Chem Lett; 2012 Jul; 22(14):4769-72. PubMed ID: 22677317 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists. Becknell NC; Dandu RR; Lyons JA; Aimone LD; Raddatz R; Hudkins RL Bioorg Med Chem Lett; 2012 Jan; 22(1):186-9. PubMed ID: 22153342 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of N-substituted spiro[benzoxazepine-piperidine] Abeta-peptide production inhibitors. Laras Y; Pietrancosta N; Tomita T; Iwatsubo T; Kraus JL J Enzyme Inhib Med Chem; 2008 Dec; 23(6):996-1001. PubMed ID: 18608784 [No Abstract] [Full Text] [Related]
17. Spiro-fused pyrrolidine, piperidine, and oxindole scaffolds from lactams. Hirschhäuser C; Parker JS; Perry MW; Haddow MF; Gallagher T Org Lett; 2012 Sep; 14(18):4846-9. PubMed ID: 22946703 [TBL] [Abstract][Full Text] [Related]